DAIC

FEBRUARY 18, 2025

Highlights include: Due to the aging population and improvement in diagnostic strategies, the prevalence of heart valve disease is expected to double by 2040 and triple by 2060.As As a result, it is estimated that the number of patients requiring heart valve interventions will increase significantly in the coming decades.

Heart Valves 52

Heart Valves Quality of Life Cardiothoracic Outcomes 52

DAIC

JUNE 24, 2024

Kittleson, director of Heart Failure Research and director of Post Graduate Medical Education in Heart Failure and Transplantation, is an associate editor specializing in heart failure. She also has served on the board of directors of the Heart Failure Society of America.

Heart Failure 100

Heart Failure Transplant Interventional Cardiology Research 100

DAIC

APRIL 9, 2024

Image courtesy of UC Davis Health milla1cf Tue, 04/09/2024 - 16:47 April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with tricuspid regurgitation , or a leaky heart valve, by using a groundbreaking catheter. Rogers , professor of cardiovascular medicine.

Tricuspid 111

Tricuspid Heart Valves Bicuspid/Mitral Quality of Life 111

DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.

Innovation 105

Innovation Aortic valve Aortic CMS 105

DAIC

JUNE 12, 2024

Additionally, the company also offers the first fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heart valve disease. “As

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105